| Graft-versus-leukemia reactions after bone marrow transplantation MM Horowitz, RP Gale, PM Sondel, JM Goldman, J Kersey, HJ Kolb, ... | 3505 | 1990 |
| Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ... New England Journal of Medicine 363 (14), 1324-1334, 2010 | 1884 | 2010 |
| NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy W Wang, AK Erbe, JA Hank, ZS Morris, PM Sondel Frontiers in immunology 6, 155000, 2015 | 643 | 2015 |
| Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings R Szydlo, JM Goldman, JP Klein, RP Gale, RC Ash, FH Bach, BA Bradley, ... Journal of clinical oncology 15 (5), 1767-1777, 1997 | 608 | 1997 |
| Differential function of major histocompatibility complex antigens in T-lymphocyte activation FH Bach, ML Bach, PM Sondel Nature 259 (5541), 273-281, 1976 | 592 | 1976 |
| Recognition by Human Vγ9/Vδ2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma Cells P Fisch, M Malkovsky, S Kovats, E Sturm, E Braakman, BS Klein, SD Voss, ... Science 250 (4985), 1269-1273, 1990 | 453 | 1990 |
| Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. AL Rakhmilevich, J Turner, MJ Ford, D McCabe, WH Sun, PM Sondel, ... Proceedings of the National Academy of Sciences 93 (13), 6291-6296, 1996 | 326 | 1996 |
| Antitumor activity of hu14. 18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study S Shusterman, WB London, SD Gillies, JA Hank, SD Voss, RC Seeger, ... Journal of Clinical Oncology 28 (33), 4969, 2010 | 318 | 2010 |
| Cell mediated immunity: separation of cells involved in recognitive and destructive phases FH Bach, M Segall, KS Zier, PM Sondel, BJ Alter, ML Bach Science 180 (4084), 403-406, 1973 | 317 | 1973 |
| HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes MJ Sheehy, PM Sondel, ML Bach, R Wank, FH Bach Science 188 (4195), 1308-1310, 1975 | 260 | 1975 |
| Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and-beta. AC Ochoa, G Gromo, BJ Alter, PM Sondel, FH Bach Journal of immunology (Baltimore, Md.: 1950) 138 (8), 2728-2733, 1987 | 248 | 1987 |
| Interferon-lnduced indoleamine 2, 3-dioxygenase activity in human mononuclear phagocytes JM Carlin, EC Borden, PM Sondel, GI Byrne Journal of Leucocyte Biology 45 (1), 29-34, 1989 | 244 | 1989 |
| Implications of interferon-induced tryptophan catabolism in cancer, autoimmune diseases and AIDS RR Brown, Y Ozaki, SP Datta, EC Borden, PM Sondel, DG Malone Kynurenine and Serotonin Pathways: Progress in Tryptophan Research, 425-435, 1991 | 243 | 1991 |
| Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial R Mody, A Naranjo, C Van Ryn, LY Alice, WB London, BL Shulkin, ... The lancet oncology 18 (7), 946-957, 2017 | 239 | 2017 |
| Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of … R DeMars, CC Chang, S Shaw, PJ Reitnauer, PM Sondel Human immunology 11 (2), 77-97, 1984 | 237 | 1984 |
| A phase I/IB trial of murine monoclonal anti‐GD2 antibody 14. G2a plus interleukin‐2 in children with refractory neuroblastoma: a report of the Children's Cancer Group JD Frost, JA Hank, GH Reaman, S Frierdich, RC Seeger, J Gan, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 232 | 1997 |
| Phase I study of chimeric human/murine anti–ganglioside GD2 monoclonal antibody (ch14. 18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma … MF Ozkaynak, PM Sondel, MD Krailo, J Gan, B Javorsky, RA Reisfeld, ... Journal of clinical oncology 18 (24), 4077-4085, 2000 | 219 | 2000 |
| Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis. P Fisch, M Malkovsky, E Braakman, E Sturm, RL Bolhuis, A Prieve, ... The Journal of experimental medicine 171 (5), 1567-1579, 1990 | 217 | 1990 |
| Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity KL Alderson, PM Sondel BioMed Research International 2011, 2011 | 211 | 2011 |
| Augmentation of Antibody Dependent Cell Mediated Cytotoxicity following in Vivo Therapy with Recombinant Interleukin 2 JA Hank, RR Robinson, J Surfus, BM Mueller, RA Reisfeld, NK Cheung, ... Cancer research 50 (17), 5234-5239, 1990 | 208 | 1990 |
